Risk aversion and COVID‐19 vaccine hesitancy

Anthony Lepinteur, Liyousew Borga, Andrew Clark, Claus Vögele and Conchita D’ambrosio
Additional contact information
Claus Vögele: uni.lu - Université du Luxembourg = University of Luxembourg = Universität Luxemburg
Conchita D’ambrosio: uni.lu - Université du Luxembourg = University of Luxembourg = Universität Luxemburg

PSE-Ecole d'économie de Paris (Postprint) from HAL

Abstract: We here investigate the role of risk aversion in COVID‐19 vaccine hesitancy. The theoretical effect is ambiguous, as both COVID‐19 infection and vaccination side‐effects involve probabilistic elements. In large‐scale data covering five European countries, we find that vaccine hesitancy falls with risk aversion, so that COVID‐19 infection is perceived as involving greater risk than is vaccination.

Keywords: COME-HERE survey; Europe; Risk aversion; Vaccine hesitancy (search for similar items in EconPapers)
Date: 2023-08
References: Add references at CitEc
Citations:

Published in Health Economics, 2023, 32 (8), pp.1659-1669. ⟨10.1002/hec.4693⟩

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
Journal Article: Risk aversion and COVID‐19 vaccine hesitancy (2023)
Working Paper: Risk aversion and COVID‐19 vaccine hesitancy (2023)
Working Paper: Risk Aversion and COVID-19 Vaccine Hesitancy (2023)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:pseptp:halshs-04206111

DOI: 10.1002/hec.4693

Access Statistics for this paper

More papers in PSE-Ecole d'économie de Paris (Postprint) from HAL
Bibliographic data for series maintained by Caroline Bauer ().